🇺🇸 FDA
Patent

US 10758496

Estrogen receptor ligand treatment for neurodegenerative diseases

granted A61KA61K2300/00A61K31/05

Quick answer

US patent 10758496 (Estrogen receptor ligand treatment for neurodegenerative diseases) held by The Regents of the University of California expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2300/00, A61K31/05, A61K31/137, A61K31/225